MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Postural Instability Assessed by Static and Dynamic Posturography in the Early Stage of Parkinson’s Disease

    A. Hajas, TW. Stone, E. Dinya, J. Málly (Sopron, Hungary)

    Objective: The early stage of Parkinson’s disease (PD) (Hoehn-Yahr (HY) I-II stages) is characterized by a negative pull test, which clinically excludes postural instability. Previous…
  • 2019 International Congress

    Paresthesia and gait impairment in a patient with advanced Parkinson disease-case report

    IE. Petre, M. Marian (Bucharest, Romania)

    Objective: Our main objective is to illustrate different etiologies for paresthesia and gait impairment that can occur in a patient with Parkinson disease. We present…
  • 2019 International Congress

    Clinimetric properties of direct contemporaneous FOG score rating

    K. Ziegler, AO. Ceballos-Baumann, UM. Fietzek (Munich, Germany)

    Objective: To determine the clinimetric properties of the direct rating of the Freezing of Gait (FOG) score compared to the off-line rating from video recordings.…
  • 2019 International Congress

    Homozygous Huntington’s disease with two reduced penetrance alleles: A Case Report

    K. Grimm, C. Zühlke, C. Gerloff, S. Zittel (Hamburg, Germany)

    Objective: To clinically characterize a Huntington's disease patient with two reduced penetrance alleles. Background: Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder manifesting with…
  • 2019 International Congress

    Intermediate CAG repeat length in the HTT gene and comorbidity – The SHAPE Study (Swedish-Huntingtin-Alleles-and-PhenotypE)

    M. Ghazarian, E. Stattin, J. Sundblom, V. Niemelä (Uppsala, Sweden)

    Objective: To 1) determine the distribution of CAG repeats of the Huntingtin gene in a Swedish general population sample, 2) explore the phenotype caused by…
  • 2019 International Congress

    Changes in GABAergic transmission of striatal neurons in presymptomatic Huntington’s Disease

    M. Treven, F. Zirpel, I. Mody (Vienna, Austria)

    Objective: To determine whether parameters of synaptic and extrasynaptic GABAergic inhibition of striatal projection neurons are altered in presymptomatic BACHD mice. Background: One attractive early…
  • 2019 International Congress

    First-In-Human Study of LY3154207, a Dopamine D1 Receptor Positive Allosteric Modulator (D1PAM)

    K. Biglan, K. Svensson, W. Kielbasa (Indianapolis, IN, USA)

    Objective: Evaluate the safety, tolerability, and plasma and cerebrospinal fluid (CSF) pharmacokinetics (PK) of LY3154207 (LY) following oral dosing in healthy subjects (HS). Background: LY,…
  • 2019 International Congress

    Long-term safety and efficacy of rimabotulinumtoxinB in the treatment of adult sialorrhea

    K. Dashtipour, S. Isaacson, M. Lew, D. Chary, T. Clinch, R. Pahwa (Boca Raton, FL, USA)

    Objective: To assess the safety, tolerability and effectiveness of repeated rimabotulinumtoxinB injections in adults with troublesome sialorrhea over a period of 1 year. Background: Sialorrhea…
  • 2019 International Congress

    A Human Factors Study of the DopaFuse® Delivery System

    J. Harmon, S. Japp, C. Long, J. Spiridigliozzi, A. Heller, B. Heller, C. King, P. Plante, R. Draper, T. Lau, E. Heller (Bala Cynwyd, PA, USA)

    Objective: SynAgile has developed the DopaFuse Delivery System to noninvasively and continuously administer oral LD/CD into the mouths of patients with PD. The System is…
  • 2019 International Congress

    The evaluation of exosomes as a biomarker of Parkinson’s disease

    Y. Ishiguro, T. Tsunemi, A. Yoroisaka, N. Hattori (Tokyo, Japan)

    Objective: This study is aimed to investigate whether the number and the contents of serum exosomes can serve as a useful biomarker for the diagnosis…
  • « Previous Page
  • 1
  • …
  • 144
  • 145
  • 146
  • 147
  • 148
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley